AmpliTech Group Posts Strong Q2 Revenue Growth but Deepens Losses on R&D Push

  • $8.07M revenue in Q2 2026, up 50.9% sequentially from $5.35M in Q1.
  • Gross profit surged 161.2% year-over-year to $2.25M (27.9% margin).
  • $3.09M net loss reported, wider than $(1.77)M in prior-year quarter.
  • $21.92M raised via Series A Rights offering in July 2026.
  • Stock repurchase program authorized for up to $10M over next 24 months.

AmpliTech's strong sequential revenue growth reflects accelerating commercialization across its RF/microwave platform, particularly in 5G and defense applications. The company is balancing aggressive R&D investments with operational scaling, a strategy that could position it for larger-volume opportunities but risks near-term profitability. With $21.92M raised via Series A Rights offering and a $10M stock repurchase program authorized, AmpliTech appears focused on maintaining financial flexibility while pursuing growth across its diversified end markets.

Execution Risk
Whether AmpliTech can sustain sequential revenue growth while managing widening net losses from R&D investments.
Market Diversification
How the company's exposure to four principal markets will drive future growth and operational leverage.
Capital Allocation
The pace at which AmpliTech deploys its $10M stock repurchase program against ongoing R&D needs.